Lilly CEO: Monoclonal Antibody Companies Should Share Coronavirus Manufacturing Capacity
Executive Summary
David Ricks says a consortium of companies will be needed to ensure enough doses of the successful candidates are available.
You may also be interested in...
Sanofi Steps Up To Lend A Hand Producing Pfizer/BioNTech's COVID-19 Vaccine In Europe
Sanofi will fill and package 100 million doses of a rival vaccine for the European market in 2021 in a sign of how the industry is working to meet an unprecedented demand for COVID-19 vaccines.
Coronavirus Update: Lilly Initiates 2,400-Patient Nursing Home Trial
Dozens of specially outfitted RVs will roll out to long-term care facilities in the US to test the prophylactic and symptom-reducing potential of the antibody Lilly is developing with AbCellera.
US DoJ Lets Biotechs Share Manufacturing Details To Speed Launch Of COVID-19 Therapies
Companies are shielded from antitrust concerns by Justice Department as they jointly prepare to manufacture whichever monoclonal-antibody-based coronavirus therapies emerge from development.